Clinical Lung Cancer

Clinical Lung Cancer is a peer-reviewed bi-monthly journal established in 1999. It features an international editorial board comprised of prominent thought leaders, including Editor-in-Chief Dr. David Gandara. It is mailed free of charge to US-based medical oncologists, hematologists, radiation oncologists and surgical oncologists. Each issue features peer-reviewed original contributions, invited comprehensive reviews and current treatment reports, commentaries, clinical trial lists, as well as meeting highlights taken from major oncology meetings throughout the year. Also included are brief editorials of current news and the latest topics concerning lung cancer issues relevant to clinicians.

Editor in Chief: David Gandara, MD
2024
clinical lung cancer
Global Print Circulation
9,500
Avg. Global Monthly Visits
12,641
Avg. Global Monthly Unique Visitors
5,640
Avg. Global Monthly Page Views
7,656
Avg. Global eTOC Distribution
8,609
Circulation updated on 1st July, 2023, based on 12-month monthly average July 2022-June 2023 eTOC Metrics: 12 Month Average of eTOC sends - July 2022 to June 2023 Monthly average web metrics based on the period of July 2022 to June 2023

Contacts

Display Advertising

Recruitment Advertising

Have a question or need assistance?

Contact us now and a Sales Representative will be in touch.